Boehringer Ingelheim is engaged in the research & development, manufacturing, and marketing of novel medications for human and veterinary applications. The company provides products for therapeutic areas, such as cardiovascular diseases, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases, and oncology. The company operates through four business segments, namely, Human Pharmaceuticals, Animal Health, Biopharmaceuticals, and Industrial Customers. Its Human Pharmaceuticals segment is engaged in the development and commercialization of APIs.
Buyer, UK Mid Market Company
Buyer, Asia Pacific Company
Buyer, Asia Pacific Mid Market Company
Buyer, UK SME Company
Buyer, Asia Pacific SME Company